Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897576415> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2897576415 endingPage "e25" @default.
- W2897576415 startingPage "e24" @default.
- W2897576415 abstract "To test the hypothesis that increased pelvic bone marrow (BM) irradiation is associated with increased hematologic toxicity (HT) in locally advanced rectal cancer (LARC) patients undergoing weekly irinotecan in combination with capecitabine-based neoadjuvant chemoradiotherapy. We analyzed 95 patients with clinical stage T3-4, N0-2 who were eligible for preoperative chemoradiotherapy and UGT1A1*28 6/6 genotype in Fudan University Shanghai Cancer Centre (FUSCC) from November 2015 to January 2018. The dose of weekly irinotecan was 80 mg/m2 for UGT1A1*28 6/6 genotype patients, whereas the dose of capecitabine was fixed at 625 mg/m2. Intensity-modulated radiation therapy (IMRT) was applied to the whole pelvis with total dose of 50 Gy in 25 fractions. Pelvic bone marrow (BM) was delineated as ilium (IL), lumbosacral (LS), lower pelvis (LP), and the relative DVHs were calculated. All patients underwent blood cell counts twice a week. The endpoint for hematologic toxicity was grade≥3 (HT3+) leukopenia, neutropenia, anemia or thrombocytopenia according to CTCAE V4.03. Logistic regression was used to analyze correlation between dosimetric parameters and grade≥3 hematologic toxicity. Linear regression models were used to test for correlation to nadir blood counts. Thirty of 95 (31.6%) patients achieved pathological complete response (PCR). Twenty of 95 (21.1%) patients experienced grade≥3 hematologic toxicity. On univariate and multivariate logistic regression, the dosimetric parameter V10 Gy to the lower pelvic BM (LP V10) was associated with grade≥3 hematologic toxicity. Increased LP V10 was associated with an increased grade≥3 hematologic toxicity (p=0.015). Patients with LP V10 ≥90% had higher rates of grade ≥3 hematologic toxicity than did patients with LP V10 <90% (33.3%, 14/42 vs. 11.3%, 6/53, p=0.01). Linear regression analysis showed iliac and lower pelvic BM dose metrics to associate with reduced nadir ANC and WCC. On multivariate analysis, only LP V10 remained associated with nadir ANC (p=0.022). These findings support the hypothesis that HT increases with increasing pelvic BM volume irradiated. Efforts to maintain LP V10 <90% may reduce grade ≥3 hematologic toxicity in LARC patients undergoing concurrent capecitabine combined with weekly irinotecan and pelvic intensity-modulated radiation therapy (IMRT)." @default.
- W2897576415 created "2018-10-26" @default.
- W2897576415 creator A5025588089 @default.
- W2897576415 creator A5026318768 @default.
- W2897576415 creator A5027126470 @default.
- W2897576415 creator A5027541188 @default.
- W2897576415 creator A5033068779 @default.
- W2897576415 creator A5053664657 @default.
- W2897576415 creator A5061240612 @default.
- W2897576415 creator A5074274861 @default.
- W2897576415 creator A5079583534 @default.
- W2897576415 date "2018-11-01" @default.
- W2897576415 modified "2023-09-23" @default.
- W2897576415 title "Association Between Bone Marrow Dosimetric Parameters and Acute Hematologic Toxicity in Locally Advanced Rectal Cancer Patients Treated with Concurrent Weekly Irinotecan in Combination with Capecitabine-Based Chemoradiotherapy and Neoadjuvant IMRT" @default.
- W2897576415 doi "https://doi.org/10.1016/j.ijrobp.2018.07.505" @default.
- W2897576415 hasPublicationYear "2018" @default.
- W2897576415 type Work @default.
- W2897576415 sameAs 2897576415 @default.
- W2897576415 citedByCount "0" @default.
- W2897576415 crossrefType "journal-article" @default.
- W2897576415 hasAuthorship W2897576415A5025588089 @default.
- W2897576415 hasAuthorship W2897576415A5026318768 @default.
- W2897576415 hasAuthorship W2897576415A5027126470 @default.
- W2897576415 hasAuthorship W2897576415A5027541188 @default.
- W2897576415 hasAuthorship W2897576415A5033068779 @default.
- W2897576415 hasAuthorship W2897576415A5053664657 @default.
- W2897576415 hasAuthorship W2897576415A5061240612 @default.
- W2897576415 hasAuthorship W2897576415A5074274861 @default.
- W2897576415 hasAuthorship W2897576415A5079583534 @default.
- W2897576415 hasBestOaLocation W28975764151 @default.
- W2897576415 hasConcept C121608353 @default.
- W2897576415 hasConcept C126322002 @default.
- W2897576415 hasConcept C143998085 @default.
- W2897576415 hasConcept C144301174 @default.
- W2897576415 hasConcept C2776694085 @default.
- W2897576415 hasConcept C2777063308 @default.
- W2897576415 hasConcept C2777909004 @default.
- W2897576415 hasConcept C2778203143 @default.
- W2897576415 hasConcept C2778239845 @default.
- W2897576415 hasConcept C2778248108 @default.
- W2897576415 hasConcept C2778424827 @default.
- W2897576415 hasConcept C2780259306 @default.
- W2897576415 hasConcept C2780873365 @default.
- W2897576415 hasConcept C29730261 @default.
- W2897576415 hasConcept C38180746 @default.
- W2897576415 hasConcept C509974204 @default.
- W2897576415 hasConcept C526805850 @default.
- W2897576415 hasConcept C71924100 @default.
- W2897576415 hasConcept C90924648 @default.
- W2897576415 hasConceptScore W2897576415C121608353 @default.
- W2897576415 hasConceptScore W2897576415C126322002 @default.
- W2897576415 hasConceptScore W2897576415C143998085 @default.
- W2897576415 hasConceptScore W2897576415C144301174 @default.
- W2897576415 hasConceptScore W2897576415C2776694085 @default.
- W2897576415 hasConceptScore W2897576415C2777063308 @default.
- W2897576415 hasConceptScore W2897576415C2777909004 @default.
- W2897576415 hasConceptScore W2897576415C2778203143 @default.
- W2897576415 hasConceptScore W2897576415C2778239845 @default.
- W2897576415 hasConceptScore W2897576415C2778248108 @default.
- W2897576415 hasConceptScore W2897576415C2778424827 @default.
- W2897576415 hasConceptScore W2897576415C2780259306 @default.
- W2897576415 hasConceptScore W2897576415C2780873365 @default.
- W2897576415 hasConceptScore W2897576415C29730261 @default.
- W2897576415 hasConceptScore W2897576415C38180746 @default.
- W2897576415 hasConceptScore W2897576415C509974204 @default.
- W2897576415 hasConceptScore W2897576415C526805850 @default.
- W2897576415 hasConceptScore W2897576415C71924100 @default.
- W2897576415 hasConceptScore W2897576415C90924648 @default.
- W2897576415 hasIssue "3" @default.
- W2897576415 hasLocation W28975764151 @default.
- W2897576415 hasOpenAccess W2897576415 @default.
- W2897576415 hasPrimaryLocation W28975764151 @default.
- W2897576415 hasRelatedWork W1569868821 @default.
- W2897576415 hasRelatedWork W1968131500 @default.
- W2897576415 hasRelatedWork W1969876278 @default.
- W2897576415 hasRelatedWork W2062135455 @default.
- W2897576415 hasRelatedWork W2062579072 @default.
- W2897576415 hasRelatedWork W2319873980 @default.
- W2897576415 hasRelatedWork W2474448941 @default.
- W2897576415 hasRelatedWork W2614664688 @default.
- W2897576415 hasRelatedWork W2616839175 @default.
- W2897576415 hasRelatedWork W2807424907 @default.
- W2897576415 hasVolume "102" @default.
- W2897576415 isParatext "false" @default.
- W2897576415 isRetracted "false" @default.
- W2897576415 magId "2897576415" @default.
- W2897576415 workType "article" @default.